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Abstract
Background: Paxillin acts as an adaptor protein that localizes to focal adhesion. This protein is
regulated during cell migration by phosphorylation on tyrosine, serine and threonine residues. Most
of these phosphorylations have been implicated in the regulation of different steps of cell migration.
The two major phosphorylation sites of paxillin in response to adhesion to an extracellular matrix
are serines 188 and 190. However, the function of this phosphorylation event remains unknown.
The purpose of this work was to determine the role of paxillin phosphorylation on residues S188
and S190 in the regulation of cell migration.
Results: We used NBT-II epithelial cells that can be induced to migrate when plated on collagen.
To examine the role of paxillin serines 188/190 in cell migration, we constructed an EGFP-tagged
paxillin mutant in which S188/S190 were mutated into unphosphorylatable alanine residues. We
provide evidence that paxillin is regulated by proteasomal degradation following polyubiquitylation
of the protein. During active cell migration on collagen, paxillin is protected from proteasome-
dependent degradation. We demonstrate that phosphorylation of serines 188/190 is necessary for
the protective effect of collagen. In an effort to understand the physiological relevance of paxillin
protection from degradation, we show that cells expressing the paxillin S188/190A interfering
mutant spread less, have reduced protrusive activity but migrate more actively.
Conclusion: Our data demonstrate for the first time that serine-regulated degradation of paxillin
plays a key role in the modulation of membrane dynamics and consequently, in the control of cell
motility.
Background
Cell migration is a cyclic multistep event that involves cell
polarization and extension of membrane protrusions at
the leading edge. At the front of the protrusion, cell-sub-
stratum adhesive complexes are formed providing trac-
tion points for translocation. Adhesive complexes at the
cell rear are then released as the cell continues to move
forward [1].
Integrins are cell-surface adhesion receptors that link the
extracellular matrix (ECM) to the intracellular actin
cytoskeleton [2]. Integrins are heterodimeric receptors
that interact with numerous structural and signaling mol-
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ecules to form large protein complexes, the focal adhe-
sions. Upon binding to ECM elements, integrins cluster
and interact with an array of structural and signaling mol-
ecules to form large protein complexes, the focal adhe-
sions. These structures are spatially regulated during cell
migration as they assemble at the leading edge to stabilize
new membrane protrusions and disassemble at the rear of
the cell to allow cell detachment [3].
The assembly process of focal adhesions at the leading
edge has been extensively examined, leading to the con-
clusion that they are highly dynamic. Their molecular
composition varies over time [4,5], thereby regulating
membrane protrusive activity and cell movement. For
instance, fast movement of the lamellipodium has been
associated with focal complexes containing relatively low
levels of paxillin whereas their slower movement with
focal complexes rich in paxillin [5].
Compared with the process of formation, less is known
about adhesion breakdown. Adhesive complexes are dis-
assembled at the rear and at the base of dynamic protru-
sions [4] in polarized migrating cells. Proteolysis of focal
adhesion components has been proposed to regulate the
protein content of adhesive complexes resulting in the
control of focal adhesion turnover and cell migration.
Calpains, cysteine proteases which localize to adhesive
structures [6], have been shown to cleave several focal
adhesion proteins, such as focal adhesion kinase (FAK)
[7], talin [8] and paxillin [9-11]. It is now accepted that
these proteases play an essential role in regulating focal
adhesion dynamics, membrane protrusion stability and
cell migration.
The ubiquitin-dependent proteasomal degradation is
another proteolytic pathway that has been implicated in
the control of focal adhesion turnover and cell migration.
Proteasomal degradation of FAK was shown to inhibit cell
migration [12]. Similarly, ubiquitylation of paxillin was
shown to affect its localization to focal adhesions and to
inhibit cell migration [13].
Paxillin is a 68 kD adapter protein that localizes to focal
adhesions. Paxillin contains many protein-protein inter-
action domains: five LD motives (Leucine-rich domains)
in the amino-terminal part and four LIM domains (dou-
ble zinc fingers) in the carboxy-terminal part. LIM
domains mediate binding to protein tyrosine phos-
phatase-PEST (PTP-PEST) [14,15], α- and γ-tubulin [16].
LIM3 is responsible for proper targeting of paxillin to
focal adhesions [17]. LD motifs mediate interactions with
an array of partners, including FAK [17] and vinculin [18].
Regulation of paxillin by phosphorylation is well docu-
mented [19]. Tyrosine residues are phosphorylated in
response to extracellular signals and serve as docking sites
for protein interactions. Phosphorylation of tyrosines 31
and 118 provides binding sites for the SH2 domain of Crk
and this interaction is necessary for cell migration [20].
Serine phosphorylation of paxillin is also a prevalent
posttranslational modification that has been extensively
examined. Paxillin serine phosphorylation is increased by
cell adhesion on fibronectin [21] or vitronectin [22]. In
contrast, during cell mitosis, which is associated with an
absence of adhesive complexes, paxillin serine phosphor-
ylation coincides with its degradation [11]. ERK and GSK-
3 have been reported to phosphorylate serines 126 and
130, respectively, leading to the relocalization of paxillin
from focal adhesions to the cytosol [23,24], while serine
178 phosphorylation by JNK is necessary for cell migra-
tion [25]. It appears therefore that the phosphorylation of
paxillin at specific serine/threonine residues could regu-
late its activity and biological functions. A function has
still to be attributed to the phosphorylation of serines 188
and 190 of paxillin, the two major phosphorylation sites
in response to cell adhesion to an extracellular matrix.
Because paxillin is a focal adhesion adaptor protein, it is
possible that specific serine phosphorylation events con-
trol its degradation rate, as already suggested [11], thereby
influencing cell movement through the regulation of focal
adhesion dynamics. The implication of paxillin in focal
adhesion turnover has been recently demonstrated. Hor-
witz and coworkers showed that the rate of focal adhesion
disassembly is slower in cells expressing several phospho-
rylation mutants or domain-deleted forms of paxillin
compared to cells expressing wild-type paxillin [26].
In this report, we found that paxillin could be ubiquit-
ylated and degraded by the proteasome. Moreover, we
show that substrates such as collagen that support cell
migration prevented paxillin degradation. Using a S188/
190A phosphorylation mutant of paxillin, we were able to
demonstrate that phosphorylation of S180/S190 was
required for the increased stability of paxillin on collagen.
We also showed that paxillin S188/190A double mutant
impaired membrane protrusion dynamics as well as cell
migration and spreading without affecting cell adhesion
on collagen.
Results
Paxillin ubiquitin-dependent proteasomal degradation is 
regulated by collagen
The turnover of focal adhesions and their components is
known to play a crucial role during cell locomotion events
[26]. To determine whether paxillin, a docking protein of
focal adhesion sites, is subjected to proteasomal degrada-
tion, NBT-II cells were treated for 4 h with lactacystin, a
selective 26S proteasome inhibitor, prior to cell lysis.
Equivalent amounts of proteins from total cell extractsCell Communication and Signaling 2006, 4:8 http://www.biosignaling.com/content/4/1/8
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were immunoprecipitated with an anti-paxillin antibody
and subjected to immunoblot with an anti-ubiquitin anti-
body. Ubiquitylation of paxillin was detected as a smear
of high molecular weight bands, corresponding to polyu-
biquitylated species (Fig. 1A). Treatment with lactacystin
strongly increased the ubiquitylated bands, indicating
that paxillin is degraded by the proteasome following its
polyubiquitylation.
We next wished to determine whether paxillin degrada-
tion could be modified under conditions allowing cell
migration. Since NBT-II carcinoma cells are induced to
migrate on collagen substrates [30], cells were labeled
with 35S-methionine/cysteine mix and chased on plastic
or collagen for 18 h in the presence or absence of lactacys-
tin. Uncoated plastic plates were used as a substrate that
does not induce cell migration. As shown in Figure 1B,
paxillin protein levels significantly decreased after 18 h
chase. Quantification of the radioactive bands migrating
with the apparent molecular weight of paxillin indicated
an approximate reduction of 70% of the newly synthe-
sized molecules during the incubation time. This decrease
was mostly due to proteasomal degradation since it could
be prevented by treatment of cells with lactacystin added
during the entire chase. In contrast, paxillin levels were
not reduced during the chase period on collagen sub-
strate. As a consequence, lactacystin had no obvious effect
on paxillin stability under those conditions. The addi-
tional bands that are visible below and above the appar-
ent size of paxillin probably represent proteins that co-
precipitated with the adaptor protein paxillin. The differ-
ences in paxillin half life in cells plated on collagen versus
plastic were apparently specific to paxillin as other pro-
teins, such as tubulin, did not exhibit similar variations
(data not shown). These experiments indicate that the
half-life of paxillin of approximately 7 h in stationary cells
on plastic is noticeably increased in motile cells on colla-
gen, suggesting that collagen prevents paxillin proteaso-
mal degradation.
It is well established that ECM protects cells from pro-
grammed cell death. To ensure that the accelerated degra-
dation of paxillin in NBT-II cells plated on plastic as
compared to collagen was not due to an increase in cell
death on plastic, the number of cells plated on each sub-
strate was evaluated over a 5-day period (Fig. 1C). No dif-
ference in cell numbers on plastic and collagen was
observed. These results suggest that collagen-induced
reduction of paxillin degradation is linked to induction of
cell motility rather than to protection from cell death.
Phosphorylation of serines 188/190 prevents paxillin from 
degradation
Serine/threonine phosphorylation events are known to
regulate ubiquitin-dependent proteasomal degradation of
several proteins [31-33]. Paxillin, originally identified as a
tyrosine phosphorylated protein [34,35], is also heavily
phosphorylated on serine/threonine residues [11,21,23-
25,36-39]. Phosphorylation of specific serine residues of
paxillin has been shown to be implicated in cytoskeleton
rearrangement and cell motility [23,25,37]. Interestingly,
two recent reports have proposed a possible link between
serine phosphorylation-dependent degradation of paxil-
lin and cell movement [25,37]. Two major sites of serine
phosphorylation are residues 188/190, previously shown
to be heavily phosphorylated upon cell adhesion to ECM
[21]. However, the role of these modifications remains
undefined.
To examine the potential role of serines 188/190 phos-
phorylation in paxillin degradation, we constructed an
EGFP-tagged paxillin mutant in which S188/S190 were
mutated into unphosphorylatable alanine residues
(S188/190A). GFP fluorescent dots were clustered at focal
adhesions at the periphery of cells transfected with either
forms of paxillin, indicating that the S188/190A paxillin
mutant localized to focal adhesions as the wild-type
EGFP-paxillin (Fig. 2A). By pulse chase analysis, we eval-
uated the stability of the mutant form as compared to wild
type paxillin. 35S-labelled transfected cells plated on either
plastic or collagen were chased for up to 7 h and the sta-
bility of exogenous paxillin was determined as described
before. In agreement with the data obtained after the 18 h
chase, the half-life of exogenously expressed wild type or
mutant paxillin in cells plated on plastic was approxi-
mately 7 h (Fig. 2B). When cells were plated on collagen,
the levels of wild type paxillin were sustained during the
chase period, as already noticed (Figure 1B). In sharp con-
trast, collagen did not stabilize EGFP-S188/190A paxillin,
as the half-life of the mutant protein of cells plated on col-
lagen was similar to that of cells on plastic (~7 h). These
observations indicate that phosphorylation of residues
S188/S190 regulates paxillin degradation and suggest fur-
thermore that this phosphorylation event is downstream
of collagen signaling.
Mutations on serines 188/190 do not affect cell adhesion 
but inhibit cell spreading
To investigate the significance of the increase in paxillin
stability induced by collagen, we analyzed the functional
effects of EGFP-S188/190A paxillin. We first determined
the kinetics of adhesion on collagen of cells transiently
expressing the EGFP-S188/190A mutant form as com-
pared to wild type paxillin. Cells were plated on increas-
ing concentrations of collagen for 1 h, fixed, and the
number of adherent cells quantified by a colorimetric
assay. Transfection efficiencies were estimated visually at
90% for both constructs and their expression were similar,
as assessed by immunoblot analysis (Fig 3A, right panel).
No significant difference in the adhesion rates of cellsCell Communication and Signaling 2006, 4:8 http://www.biosignaling.com/content/4/1/8
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Paxillin proteasomal degradation is regulated by collagen Figure 1
Paxillin proteasomal degradation is regulated by collagen. A) NBT-II cells plated for 18 h on plastic dishes were 
treated with the proteasome inhibitor lactacystin at 1 μM for 4 h. Cell lysates were immunoprecipitated with anti-paxillin anti-
body and immunoblot analysis was done with anti-ubiquitin (upper panel) or anti-paxillin antibody (lower panel). B) NBT-II cells 
were pulse-chased on plastic or collagen-coated dishes for 18 h and cell lysates were subjected to paxillin immunoprecipitation 
as described in Materials and Methods. When indicated, 1 μM lactacystin was added to the cells during the chase period. The 
lower panel is a quantification of the bands corresponding to 35S-labeled paxillin. The 35S-paxillin levels were calculated rela-
tively to the density of the paxillin band immunoprecipitated from cells at the beginning of the radioactive chase (control lane). 
C) NBT-II cells cultured for the indicated times on plastic or collagen-coated dishes were trypsinized and counted using a 
hemocytometer. Values represent the mean of three independent experiments ± SEM.Cell Communication and Signaling 2006, 4:8 http://www.biosignaling.com/content/4/1/8
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Collagen protects EGFP-S188/190A from degradation Figure 2
Collagen protects EGFP-S188/190A from degradation. A) NBT-II cells transfected with EGFP-paxillin or EGFP-S188/
190A were plated on glass cover-slips for 18 h prior to fixation. The localization of the fusion proteins was observed by EGFP-
fluorescence microscopy. B) NBT-II cells expressing wild type or mutant paxillin were pulse-chased on plastic or collagen-
coated dishes for the indicated times. Cell lysates were immunoprecipitated with paxillin antibody prior to SDS-PAGE followed 
by autoradiography (left panels). The upper arrowhead points to EGFP-paxillin proteins bands and the lower arrowhead to 
endogenous paxillin bands. By densitometric analyses, mean exogenous 35S-paxillin levels were calculated relatively to the den-
sity of the paxillin band in the control lane. Means and SEM from 3 independent experiments were then calculated. The Stu-
dent's t test was used to evaluate the data (right panels). *, p < 0.05.Cell Communication and Signaling 2006, 4:8 http://www.biosignaling.com/content/4/1/8
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expressing either EGFP-paxillin or EGFP-S188/190A was
observed, both cell types achieving half-maximal adhe-
sion at 0.5 μg/ml, with maximal adhesion at 2.5 μg/ml.
These results are in agreement with a previous report
showing that the S188/190A paxillin double mutant has
no effect on the adhesion rate of CHO-K1 cells on
fibronectin [36].
We next analyzed the effect of the S188/190A paxillin
mutant on cell spreading on collagen. Cells expressing
EGFP-paxillin or EGFP-S188/190A were plated on colla-
gen (10 μg/ml) for 30, 60, 120 and 240 min, and the
number of EGFP-positive spread cells estimated after fixa-
tion. Cells expressing the S188/190A mutant spread
slower than those expressing wild-type paxillin (Fig. 3B).
Two hours after plating cells on collagen, there was a
reproducible and significant 15% decrease in the ratio of
spread cells expressing EGFP-S188/190A paxillin as com-
pared to EGFP-paxillin (p < 0.001). These results suggest
that phosphorylation on serines 188/190 contributes to
cell spreading on collagen but not to cell attachment. Fur-
thermore, these data argue for a dominant negative effect
of S188/190A paxillin double mutation. The presence of
endogenous paxillin may minimize the inhibition due to
the mutant molecule. Alternatively, the moderate inhibi-
tion is comprehensible, considering that paxillin S188/
S190 phosphorylation is only one element of the signal-
ing pathway(s) leading to cell spreading.
Mutations on serines 188/190 enhance random cell 
migration on collagen
Serine phosphorylations of paxillin have been shown to
be involved in cell migration [25,40]. To determine
whether the S188/190A mutant of paxillin affected ran-
dom cell migration induced by collagen, we used time-
lapse videomicroscopy to follow the movement of iso-
lated cells expressing EGFP-tagged paxillin during 10 h.
Using Metamorph software, we quantified the migration
rate as the total distance traveled by one cell divided by
the time of recording. On non-permissive substrates such
as plastic plates, the absence of active cell migration of
cells expressing the S188/190A paxillin mutant (10.71
μm/h ± 6.07) was in the same range as that of cells
expressing EGFP-paxillin (5.46 μm/h ± 1.37). Mutations
of paxillin S188/S190 into unphosphorylatable residues
significantly increased migration on collagen (27.98 μm/
h ± 1.21) as compared to cells expressing wild type paxil-
lin (20.95 μm/h ± 1.09). Therefore, phosphorylation of
residues S188/S190 is negatively implicated in cell migra-
tion on collagen.
Mutations on S188/S190 inhibit membrane protrusion 
dynamics
Because mutations of S188/S190 into alanine residues
accelerated NBT-II cell migration on collagen, we wanted
to examine whether this mutation affected the cell protru-
sive activity, which plays an essential role in generating
cell migration. Cells transiently expressing EGFP-paxillin
or EGFP-S188/190A were plated on collagen-coated 6-
well plates for 4 h. Using time-lapse videomicroscopy,
light-transmission images of cells were taken every 15 sec
for 5 min (Fig. 4A). The change in cell area of protrusions
over time was calculated as described under Materials and
Methods and the frequency distribution in the cell popu-
lation shown in Figure 4B. Most cells expressing wild type
paxillin had a change in cell area greater than 200 μm2,
with a homogenous distribution above that value. In
sharp contrast, the majority of cells expressing S188/190A
paxillin were found in the group of low protrusive activity
( < 200 μm2). Because the reduction of protrusiveness
observed in cells expressing the paxillin mutant could be
due to a decrease either in the number of extended protru-
sions or in the dynamic of these protrusions, we analyzed
two additional parameters. First, we calculated the total
number of protrusions extended by each GFP-positive cell
during the 5 min period of acquisition (Fig. 4C). Given
the kinetics of extension/retraction of protrusions in NBT-
II cells (data not shown), the 15 sec interval between two
successive images was short enough to include unstable as
well as stable protrusions. By comparing the number of
membrane extensions in cells expressing wild type versus
mutant forms of paxillin during the 5 min recording, we
observed that expression of the S188/190A paxillin
mutant significantly reduced the number of protrusions
emitted by cells (Fig. 4C). We then evaluated the mean
activity of protrusions in cells expressing either EGFP-
S188/190A or EGFP-paxillin (Fig. 4D). Cells expressing
mutant paxillin had a 60% decrease in collagen-induced
protrusive activity as compared to cells expressing wild
type paxillin. Collectively, these two sets of data indicate
that the reduction in cell protrusive activity was due to a
reduction both in the number of protrusions and in indi-
vidual protrusion dynamics. These results also indicate
that serine phosphorylation of residues 188/190 is neces-
sary for membrane protrusion extension/retraction.
Discussion
In this study, we provide evidence that paxillin levels can
be regulated by proteasomal degradation following poly-
ubiquitylation of the protein. On collagen, which sustains
active cell migration of NBT-II cells, paxillin is protected
from proteasome-dependent degradation leading to an
increase in its half-life. In addition, we demonstrate that
phosphorylation of serine residues 188 and 190 is neces-
sary for the protective effect of collagen. When S188/S190
phosphorylation is prevented by mutating the two resi-
dues into alanine, several functional consequences can be
observed. Cells spread less, have reduced protrusive activ-
ity and migrate more actively. Collectively, our data dem-
onstrate for the first time that serine-regulatedCell Communication and Signaling 2006, 4:8 http://www.biosignaling.com/content/4/1/8
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Cells expressing EGFP-paxillin or EGFP-S188/190A paxillin have similar adhesion but different spreading and migration rates on  collagen Figure 3
Cells expressing EGFP-paxillin or EGFP-S188/190A paxillin have similar adhesion but different spreading and 
migration rates on collagen. A) NBT-II cells transfected with EGFP-paxillin or EGFP-S188/190A were allowed to adhere on 
dishes coated with collagen at the indicated concentrations for 1 h at 37°C. Absorbance values were obtained by crystal violet 
uptake assay and expressed as percent of maximal adhesion. Values represent the mean of three independent experiments car-
ried out in triplicate ± SEM (left panel). Expression of endogenous and transfected paxillin is shown on the right panel. B) Cell 
spreading was quantified by allowing cells to adhere onto collagen coated plates (10 μg/ml) for the indicated times. The per-
centage of spread cells among the GFP-positive population was then calculated for each time point. Values represent the mean 
of three independent experiments carried out in triplicate ± SEM (left panel). Expression of endogenous and transfected paxil-
lin is shown on the right panel. C) NBT-II cells transfected with either plasmids were plated on plastic or collagen-coated plates 
(10 μg/ml) for 4 h. Cell motility was evaluated by tracking individual cells for 10 h using the Metamorph software. Mean migra-
tion rate of cells is expressed as μm/h. Values represent the mean of three independent experiments ± SEM (left panel). 
Expression of endogenous and transfected paxillin is shown on the right panel. **, p < 0.01Cell Communication and Signaling 2006, 4:8 http://www.biosignaling.com/content/4/1/8
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degradation of paxillin plays a key role in the modulation
of membrane dynamics and consequently, in the control
of cell motility.
In line with our data, degradation of paxillin by two dif-
ferent mechanisms has already been reported. On one
hand, it was shown to depend on a calpain-regulated
process [9-11]. On the other hand, ubiquitylation of pax-
illin was postulated to lead to selective degradation of the
focal adhesion-associated insoluble pool but not the
cytosolic pool of the protein [13]. This suggests that the
ubiquitylated forms of paxillin degraded in the NBT-II cell
Expression of EGFP-S188/190A paxillin inhibits membrane protrusion dynamics Figure 4
Expression of EGFP-S188/190A paxillin inhibits membrane protrusion dynamics. NBT-II cells expressing either 
paxillin constructs were plated on collagen-coated plates (10 μg/ml) for 4 h. Images of GFP-positive cells were taken on a fluo-
rescence inverted microscope every 15 sec for 5 min. A) Representative images of cells expressing wild type or mutant paxillin 
used in protrusion analysis (performed as described in Materials and Methods) were taken from time-lapse series. Arrowheads 
point to stable and arrows to dynamic protrusions. Note the number of protrusions and their lability in EGFP-paxillin cell com-
pared to cell expressing mutant paxillin. B) Protrusiveness was calculated as the net change in cell area (μm2). The distribution 
of protrusiveness within the cell population is shown. C) The mean number of protrusions per cell ± SEM was calculated by 
adding the cell extensions observed in all images and dividing the resulting figure by the number of images in the movie. D) 
Membrane protrusion index, which was quantified as described under Materials and Methods, represents the mean activity of a 
single protrusion. Data are the average of three independent experiments ± SEM. ***, p < 0.001.Cell Communication and Signaling 2006, 4:8 http://www.biosignaling.com/content/4/1/8
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line used in our study could belong mainly to the adhe-
sive contact-associated pool of the protein. In NBT-II cells,
the insoluble pool of paxillin corresponds to approxi-
mately 30% of total paxillin (data not shown).
Using a non-phosphorylatable mutant of paxillin at ser-
ines 188 and 190, we found that phosphorylation of these
sites was necessary for paxillin stabilization by collagen.
The mechanism by which this effect is achieved remains
elusive. Phosphorylated S188/S190 may constitute a reg-
ulated docking site for a protein partner, thereby seques-
tering paxillin away from the proteasomal machinery of
degradation. Alternatively, S188/S190 phosphorylation
may prevent other posttranslational modifications of the
molecule required for ubiquitylation and/or degradation.
In an attempt to investigate the significance of the
increased paxillin stability induced by S188/190 phos-
phorylation on collagen, we demonstrate that phosphor-
ylation on serines 188/190 is not necessary for cell
adhesion but is important for cell spreading. It is now
accepted that paxillin plays an important role in cell
spreading since a number of mutants act in a dominant-
negative fashion to reduce this process. CHO.K1 fibrob-
lasts stably expressing a paxillin variant lacking the LD4
motif present a defect in cell spreading on fibronectin
[41]. Expression of the ERK/GSK-3 phosphorylation site
double mutant, S126/130A, also strongly inhibits cell
spreading of paxillin-null fibroblasts on fibronectin [23].
Collectively, these data suggest that paxillin may control
cell spreading through multiple signaling pathways.
We also noticed that expression of EGFP-S188/190A pax-
illin increases cell migration on collagen but not basal cell
motility (on plastic), indicating that phosphorylation of
serines 188 and 190 regulates collagen-induced but not
basal cell migration. To our knowledge, this is the first
time that serine phosphorylation of paxillin is shown to
be negatively involved in cell motility. These results sug-
gest that the function of paxillin may be orchestrated by
an array of negative as well as positive posttranslational
modifications. They could be combined on the same mol-
ecule leading to an integrated behavior or, alternatively,
could arise on molecules localized at different intracellu-
lar sites. In the present study, we observe that cells express-
ing EGFP-S188/190A paxillin mutant spread less but
migrate more on collagen than control cells. Reduction in
cell spreading induced by the expression of mutant paxil-
lin is consistent with an increase in cell motility, as cells
derived from mice deficient in the focal adhesion mole-
cule vinculin likewise show reduced cell spreading and
increased cell migration [42].
In addition to negatively regulating cell migration, phos-
phorylation of paxillin serines 188/190 is important for
the collagen-mediated increase in protein stability. In this
respect, paxillin ubiquitylation was previously reported to
be associated with the inhibition of cell migration [13].
Proteasomal degradation of another focal adhesion pro-
tein, FAK, was also shown to inhibit cell migration [12].
Moreover, we observed an inverse correlation between
cell migration and membrane protrusion dynamics. In
that sense, it is commonly accepted that in order for a cell
to translocate properly, membrane protrusions at the
leading edge of the cell need to be stabilized, leading to a
reduction of protrusion dynamics [43].
Our results also show that a decrease in paxillin stability
is associated with a decrease in protrusion dynamics.
There are conflicting reports about the role of localized
proteolysis at the leading edge of cells in regulating lamel-
lipodia dynamics. Calpain activity was found to be neces-
sary for stabilizing protrusions at the leading edge of
migrating cells [9,44]. In contrast, other studies support a
role for calpains in limiting membrane extensions
[9,45,46], suggesting that calpains may function both as a
negative and positive regulator of protrusion events. It is
required for stabilization of protrusions at the leading
edge while suppressing protrusions in other parts of the
cell. Other critical mediators of cell motility, including
Rho-pathway components, have a similar relationship
between their activities and protrusion stabilization/
retraction events, serving both as negative and positive
regulators of cell motility [47, 48, 49, 50]. We postulate
that proteasome-dependent proteolysis of focal-adhesion
molecules such as paxillin may serve similar functions.
Degradation of paxillin would be inhibited in stabilized
protrusions while taking place in labile membrane exten-
sions, leading to polarization of the cell in the direction of
movement. Further experiments are required to explore
the role of S188/190 phosphorylation in polarization of
cell migration and to establish whether the two serines are
equally implicated in these effects.
Methods
Reagents and antibodies
Lactacystin, used at 1 μM, was from Calbiochem (Darm-
stadt, Germany). Monoclonal antibodies against paxillin
(clone 349) and ubiquitin (clone P4D1) were from Trans-
duction Laboratories (Lexington, KY, USA) and Santa
Cruz Biotechnology (Santa Cruz, CA, USA), respectively.
Rat type I collagen was from BD Bioscience (San Jose, CA,
USA).
Plasmids
Complementary DNA coding for chicken S188/190A
mutant paxillin in the pcDNA3 expression vector was
kindly provided by Dr. C.E. Turner (State University of
New York, Syracuse, NY, USA). To construct the EGFP-
tagged paxillin S188/190A mutant, the pcDNA3-S188/
190A plasmid was subcloned in EGFP-C3 plasmid (Invit-Cell Communication and Signaling 2006, 4:8 http://www.biosignaling.com/content/4/1/8
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rogen, Carlsbad, CA, USA) using BamHI and XbaI restric-
tion sites. The wild-type EGFP-paxillin was previously
described [20]. All constructs were sequenced prior to use
(MWG-Biotech, Ebersberg, Germany).
Cell culture and transfection
NBT-II carcinoma cell line was cultured routinely in
DMEM (Gibco BRL-Invitrogen, Carlsbad, CA, USA) sup-
plemented with 1% glutamine and 10% heat-inactivated
fetal calf serum as previously described [27].
For immunoprecipitation experiments, 1.5 × 106  cells
plated one day before in 60-mm dishes were transfected
with 6 μg DNA and polyethylenimine (Sigma, St. Louis,
MO, USA) in DMEM for 3 h 30 as described before [28].
For all other experiments, 2 × 106 cells plated one day
before in 60-mm dishes were transfected with Lipo-
fectamine™ 2000 (Invitrogen) following the manufac-
turer's recommendations.
Western blots and immunoprecipitations
Cells were trypsinized, resuspended in complete medium
for 15 min and replated on plastic dishes or on plates pre-
coated overnight at 4°C with collagen (10 μg/ml). For
western blotting experiments, cells were lysed with NP-40
buffer (1% NP-40, 50 mM Tris pH 8.0, 150 mM NaCl, 5
mM EDTA), protease inhibitors (Complete tablets, Roche
Diagnostics, Mannheim, Germany) and a cocktail of
phosphatase inhibitors (1 mM Na-orthovanadate, 1 mM
Na-pyrophosphate, 25 mM β-glycerophosphate, 1 mM
Na-fluoride). For immunoprecipitations, cells were lysed
with Triton buffer (1% Triton X-100, 10 mM Tris pH 7.4,
150 mM NaCl, 1 mM EDTA, Complete proteases and
phosphatase inhibitors). Immunoprecipitations were per-
formed on equivalent amounts of proteins as described
before [20].
For Western blot analysis of paxillin, equivalent amounts
of proteins were separated by SDS-PAGE electrophoresis
and transferred onto polyvinylidene membranes (Immo-
bilon P, Millipore Corp., Bedford, MA, USA). Western
blot detection of paxillin was performed essentially as
described previously [20].
Ubiquitylation of paxillin
Cells were lysed in 1% Triton X-100, 1% SDS, 20 mM Tris
pH7.5, 150 mM NaCl, 1 mM CaCl2, 10 mM N-ethylmale-
imide, protease and phosphatase inhibitors, diluted 10
times in the same buffer without SDS and 1 mg of pro-
teins was used for paxillin immunoprecipitation. Samples
were separated by SDS-PAGE and subjected to Western
blotting with an anti-ubiquitin antibody.
Pulse chase analysis
Non-transfected or cells transfected with plasmids encod-
ing for EGFP-paxillin or EGFP-S188/190A paxillin were
harvested by trypsinization and maintained in suspension
in complete medium without methionine and cysteine for
30 min at 37°C. One hundred μCi of 35S-methionine/
cysteine mix (Redivue™ PRO-MIX™, Amersham Bio-
sciences, Piscataway, NJ, USA) was added per 1 × 106 cells.
Cells were then washed 3 times in radioactive-free
medium and plated onto plastic or collagen-coated plates
and incubated at 37°C for increasing periods of time prior
to cell lysis. 1.5 × 106 cells were lysed and paxillin immu-
noprecipitation was done as described previously. Pro-
teins were separated by SDS-PAGE electrophoresis, gels
were dried and exposed to autoradiographic films (Amer-
sham Biosciences). Quantification of the autoradiographs
from three independent experiments was done using
Image J free software (NIH, USA). Means and SEM were
then calculated. The Student's t test was used to evaluate
the data.
Cell proliferation assay
NBT-II cells (7.5 × 104 cells) were plated in 60-mm culture
dishes pre-coated with collagen (10 μg/ml) and allowed
to grow at 37°C. Each day, cells were trypsinized and
counted using a hemocytometer.
Cell adhesion and spreading
NBT-II cells transiently expressing EGFP-paxillin or EGFP-
S188/190A paxillin were trypsinized, washed 3 times with
DMEM and resuspended in 100 μl of DMEM. Eighty thou-
sand cells were then plated on 96 well plates pre-coated
overnight at 4°C with increasing concentrations of colla-
gen and saturated for 1 h at room temperature with 5%
BSA (Sigma). Non-specific cell adhesion was measured on
wells coated with BSA only. After incubation at 37°C for
1 h, wells were washed 3 times with DMEM to remove
non-adherent cells. The remaining adherent cells were
fixed for 20 min with 3.8% paraformaldehyde, washed
extensively and then stained for 10 min with 5% crystal
violet in methanol. Plates were then washed with water
until the excess dye was removed. Crystal violet incorpo-
rated within the cells was released with 100 μl acetic acid
(10% v/v) and the absorbance was quantified at 580 nm.
All experiments were performed in triplicate with at least
three independent experiments done. Means and SEM
were then calculated. The Student's t test was used to eval-
uate the data.
For cell spreading assays, NBT-II transfected cells were
trypsinized, washed 3 times with DMEM, resuspended at
a concentration of 0.5 × 106 cells/ml. Cells were then
plated on 6 wells plates pre-coated with 10 μg/ml colla-
gen. After incubation at 37°C for the indicated times,
attached cells were fixed with 3.8% paraformaldehyde forCell Communication and Signaling 2006, 4:8 http://www.biosignaling.com/content/4/1/8
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20 min at room temperature. Round phase bright, refrac-
tile cells were scored as unspread. Phase dark, nonrefrac-
tile cells and cells that were elongated were defined as
spread. Spreading was calculated as the ratio between
spread and attached GFP-positive cells. All experiments
were done in duplicate with at least three independent
experiments performed. Means and SEM were calculated.
The Student's t test was used to evaluate the data.
Cell migration assay
Eighteen hours after transfection with EGFP-tagged con-
structs, 105 cells were trypsinized and plated on plastic or
collagen-coated 35-mm Petri dishes in complete medium.
After 4 h, the dish was placed on the motorized stage of a
Leica 2D multi-positioning inverted microscope micros-
copy (Leica Microsystems, Wetzlar, Germany) equipped
with a chamber providing controlled temperature and
CO2 concentration. Phase-contrast and fluorescent images
were acquired from a cool SNAP™ CCD camera (Photo-
Metrics, Tucson, AZ, USA). Image acquisition was control-
led using the Metamorph software (Universal Imaging
Corp., Downingtown, PA, USA). Images of the fluores-
cently tagged cells were acquired at the beginning of the
experiment. Phase-contrast time-lapse movies were then
recorded at 4-minutes intervals. Motility of individual
cells was evaluated by tracking their movement during 10
h using Metamorph software. The average speed of loco-
motion (μm/h) was calculated as the total track length
divided by the number of hours recorded. For each exper-
imental condition, 50–100 GFP-expressing cells were
recorded and analyzed. At least three independent experi-
ments were performed for each condition. Means and
SEM were calculated. The Student's t test was used to eval-
uate the data.
Immunofluorescence
NBT-II cells were trypsinized 24 h after transient transfec-
tion and plated on glass cover-slips for an additional 24 h.
Cells were then fixed with 4% paraformaldehyde for 20
min and permeabilized with 0.1% Triton X-100 for 2 min
prior to incubation with 100 μM 4'6-diamidino-2-phe-
nylindole (DAPI, Sigma, St. Louis, MO, USA) for 5 min.
The cover-slips were mounted in PBS/glycerol+100 mg/
ml 1,4-diazabicyclo [2.2.2]octane (DABCO, Sigma) and
observed using a 100× objective by 3D immunofluores-
cence microscopy (Leica Microsystems). Images were
deconvoluted and treated using the Metamorph software.
Membrane protrusion dynamics
Membrane protrusion analysis was performed using a 40×
objective on a 2D multi-positioning inverted fluorescence
microscope (Leica Microsystems). Phase-contrast images
were captured at 15 sec intervals for 5 min using a Cool
SNAP™ CCD camera. In each experiment, at least 5 fields
were analyzed per condition. For each condition, a total of
35–50 cells were scored in 5 independent experiments.
Membrane protrusion analysis was done using Image J
software and based on a program described elsewhere
[29] with slight modifications. Briefly, a black mask cov-
ering the cell was drawn for every plane in the stack.
Binary images in which cell was in black against a white
background were obtained using the threshold. Subse-
quent images in the stack were overlaid with each other
and a differential image created. Any pixel undergoing a
change in gray value was scored as positive. A binary
image was then created in which positive pixels were dis-
played as black against a white background. The total
black pixels for a single cell in the 5-minutes interval were
then scored. For each experiment, the average number of
pixels displaying a change in gray level was determined. It
was converted into change in cell area by taking into
account the real size of pixels. Two other parameters were
analyzed: the number of protrusions per cell was calcu-
lated by adding the number of extensions present at the
cell periphery in the 21 images of the entire movie. The
protrusive index represents the ratio of the change in cell
area divided by the number of protrusions.
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